![]() |
|
|
Vol. 62, Issue 6, 1332-1338, December 2002
Institut de Chimie Biologique and Institut National de la
Santé et de la Recherche Médicale U-338, Faculty of
Medicine, Strasbourg, France (C.A., C.M., C.S.-M., S.G., D.A., M.M.)
and Institut de Recherche International Servier, Neuilly-sur-Seine,
France (M.S.)
Differential display reverse transcription-polymerase chain
reaction was used to identify mRNAs that are differentially expressed in the brain of rats treated chronically with the reference tricyclic antidepressant, imipramine, in comparison with control rats. The gene
encoding for a mutation suppressor for Sec4-8 yeast
(Mss4) transcript is overexpressed in the amygdala of
treated rats after 3 weeks of daily administration. This overexpression
is also found in the hippocampus of rats treated chronically with
either tianeptine or fluoxetine. Mss4 protein has the properties of a
guanine nucleotide exchange factor, interacting with several members of
the Rab family implicated in Ca2+-dependent exocytosis of
neurotransmitters. Mss4 was also overexpressed in other brain
structures as judged by in situ hybridization. The kinetics of the
up-regulation of Mss4 gene expression measured by Northern blot during
the imipramine, tianeptine, or fluoxetine treatments are consistent
with an antidepressant effect that occurs after 3 weeks. In rats in
which anhedonia was induced by chronic mild stress during 3 weeks, Mss4 transcripts were specifically down-regulated in
hippocampus and amygdala compared with control rats. It is proposed
that Mss4 protein, which stimulates exocytosis in vivo, participates in
the potentiation of the activity of neurotransmitter pathways
implicated in the action of several antidepressants and constitutes one
of the common functional molecules induced after chronic antidepressant treatment.